CCNA2 and colorectal carcinoma: In SW480 and SW620 CRC cells δ-valerobetaine, a constitutive milk metabolite with antioxidant, anti-inflammatory, and anti-diabetic activities, impaired cell viability in a time-dependent way, blocked cell cycle at G2/M increasing the expression of cyclin A and cyclin B protein [14,17,47].